‘Designer drugs’: update to the administration of novel psychoactive compound misuse during the acute treatment settingN-Ethylhexedrone provides cross-tolerance with all noradrenergic and dopaminergic stimulants, that means that once the consumption of N-ethylhexedrone all stimulants can have a reduced outcome. PsychosisInspite of similarities